Clinical Trials Browser

Withdrawn × Interventional × Breast Carcinoma In Situ × Clear all

NCT03868475 2026-03-09

VAPEX

Phase NA Withdrawn

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Cicatrix, Phyllodes Tumor, Patient Satisfaction, Fibroadenoma

NCT03666819 2023-01-06

Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy

Phase 2 Withdrawn

Breast Carcinoma In Situ, Dyspareunia

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms

NCT01729832 2017-04-13

Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer

Phase NA Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00041353 2013-07-11

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Phase NA Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01055678 2012-12-17

To Evaluate the Characteristics of a Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular

NCT00324714 2012-11-29

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Phase 3 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Osteoporosis